Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.74 |
| ▸ | NAAA | Q02083 | 1/20 | 0.62 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.61 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.61 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.61 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.61 |
| ▸ | HTR2C | P28335 | 1/20 | 0.59 |
| ▸ | PAM | P19021 | 2/20 | 0.56 |
| ▸ | ACHE | P22303 | 6/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dodecanol SCHEMBL2369293 | 1.00 | DGKA (0.74) | DGKANAAAPRSS1PRSS2PRSS3 | |
| SCHEMBL2518708 | 1.00 | DGKA (0.74) | DGKANAAAPRSS1PRSS2PRSS3 | |
| SCHEMBL20067021 | 1.00 | DGKA (0.74) | DGKANAAAPRSS1PRSS2PRSS3 | |
| SCHEMBL21800953 | 1.00 | DGKA (0.74) | DGKANAAAPRSS1PRSS2PRSS3 | |
| SCHEMBL20740271 | 1.00 | DGKA (0.74) | DGKANAAAPRSS1PRSS2PRSS3 | |
| SCHEMBL2802141 | 1.00 | DGKA (0.74) | DGKANAAAPRSS1PRSS2PRSS3 | |
| SCHEMBL2145746 | 1.00 | DGKA (0.74) | DGKANAAAPRSS1PRSS2PRSS3 | |
| SCHEMBL3443790 | 1.00 | DGKA (0.74) | DGKANAAAPRSS1PRSS2PRSS3 | |
| SCHEMBL8981714 | 1.00 | DGKA (0.74) | DGKANAAAPRSS1PRSS2PRSS3 | |
| SCHEMBL17335289 | 1.00 | DGKA (0.74) | DGKANAAAPRSS1PRSS2PRSS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 318 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4633581-A1 | A TOPICAL COMPOSITION | Rock & Herb Pte Ltd (SG) | 2025-10-22 | — | — | EP | claimed |
| CN-119799167-A | Chemical mechanical polishing liquid for silicon wafer, preparation method and application | 万华化学集团股份有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-118948631-B | Oil-in-water cleansing composition | 深圳市护家科技有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-119015394-A | Sulfur-containing compound preparation, and preparation method and application thereof | 上海优斐斯生物科技有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-118948631-A | Oil-in-water cleansing composition | 深圳市护家科技有限公司 | 2024-11-15 | — | — | CN | claimed |
| WO-2024128980-A1 | A TOPICAL COMPOSITION | ROCK & HERB PTE LTD (SG) | 2024-06-20 | — | — | WO | claimed |
| CN-116370328-A | Skin care composition and external skin preparation | 深圳市护家科技有限公司 | 2023-07-04 | — | — | CN | claimed |
| CN-114224765-A | Amino acid shampoo and preparation method thereof | 上海佰太生物科技有限公司 | 2022-03-25 | — | — | CN | claimed |
| US-11202741-B2 | Self-restorable core-shell capsule | AMOREPACIFIC CORPORATION (KR) | 2021-12-21 | — | — | US | claimed |
| CN-110359157-A | A kind of preparation method of the fabric with crease-resistant health care | 南通北岸纺织科技有限公司 | 2019-10-22 | — | — | CN | claimed |
| US-8193137-B2 | Thickening composition | AJINOMOTO CO., INC. (JP) | 2012-06-05 | — | — | US | claimed |
| CN-100556395-C | Non-pressurized post-application expanding compositions | AVON PROD INC (US) | 2009-11-04 | — | — | CN | claimed |
| EP-1575546-A4 | NON-PRESSURIZED POST-APPLICATION EXPANDING COMPOSITION | AVON PROD INC (US) | 2009-04-01 | — | — | EP | claimed |
| US-20060147399-A1 | Non-pressurized post-application expanding composition | CITIBANK, N.A., LONDON BRANCH | 2006-07-06 | — | — | US | claimed |
| CN-1703196-A | Non-pressurized post-application expanding compositions | AVON PROD INC (US) | 2005-11-30 | — | — | CN | claimed |
| EP-1575546-A2 | NON-PRESSURIZED POST-APPLICATION EXPANDING COMPOSITION | Avon Products, Inc. (US) | 2005-09-21 | — | — | EP | claimed |
| WO-2004060292-A2 | NON-PRESSURIZED POST-APPLICATION EXPANDING COMPOSITION | AVON PRODUCTS, INC. (US) | 2004-07-22 | — | — | WO | claimed |
| US-5888478-A | COSMETIC; CLEANING COMPOUNDS | L'OREAL (FR) | 1999-03-30 | — | — | US | claimed |
| EP-0792632-B1 | Pressurized transparent apparatus with a foaming composition containing non ionic and amphoteric surfactants | OREAL (FR) | 1998-05-06 | — | — | EP | claimed |
| US-4198204-A | ADDING AN ANIONIC AND/OR NONIONIC ALIPHATIC SURFACTANT | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-04-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060147399-A1 | Non-pressurized post-application expanding composition | NONO, SMURF1, SMURF2 | DGKA 1737/4885NAAA 2992/4885PRSS1 4524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.